These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9488931)

  • 41. Biochemical markers for monitoring response to therapy: evidence for higher bone specificity by a novel marker compared with routine markers.
    Leeming DJ; Hegele A; Byrjalsen I; Hofmann R; Qvist P; Karsdal MA; Schrader AJ; Wagner R; Olbert P
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1269-76. PubMed ID: 18483350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Markers of bone turnover in prostate cancer.
    Garnero P
    Cancer Treat Rev; 2001 Jun; 27(3):187-92; discussion 193-6. PubMed ID: 11417970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.
    Lehrer S; Diamond EJ; Stagger S; Stone NN; Stock RG
    Br J Cancer; 2002 Sep; 87(7):726-8. PubMed ID: 12232754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer.
    Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
    Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer.
    Hegele A; Wahl HG; Varga Z; Sevinc S; Koliva L; Schrader AJ; Hofmann R; Olbert P
    BJU Int; 2007 Feb; 99(2):330-4. PubMed ID: 17092281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease.
    Miyakawa M; Tsushima T; Demura H
    Endocr J; 1996 Dec; 43(6):701-8. PubMed ID: 9075610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Markers of bone turnover for the management of patients with bone metastases from prostate cancer.
    Garnero P; Buchs N; Zekri J; Rizzoli R; Coleman RE; Delmas PD
    Br J Cancer; 2000 Feb; 82(4):858-64. PubMed ID: 10732759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between bone scintigraphy and serum levels of procollagen (I) and PSA in the detection of bone disease in prostate cancer patients.
    Zissimopoulos A; Bantis A; Stellos K; Petrakis G; Matthaios D
    J BUON; 2008; 13(1):69-74. PubMed ID: 18404790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic value of some biochemical bone markers for the detection of bone metastases in prostate cancer.
    Westerhuis LW; Delaere KP
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):89-94. PubMed ID: 9056749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum levels of bone turnover markers parallel the results of bone scintigraphy in monitoring bone activity of prostate cancer.
    Noguchi M; Yahara J; Noda S
    Urology; 2003 May; 61(5):993-8. PubMed ID: 12736022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The serum level of the amino-terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone.
    Koizumi M; Yonese J; Fukui I; Ogata E
    BJU Int; 2001 Mar; 87(4):348-51. PubMed ID: 11251528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diagnostic values of serum type III procollagen N-terminal peptide in type IV gastric cancer].
    Akazawa S; Fujiki T; Kanda Y; Kumai R; Yoshida S
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):861-6. PubMed ID: 3985646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between serum levels of interleukin-6, tumor necrosis factor-alpha and bone turnover markers in prostate cancer patients.
    Akimoto S; Okumura A; Fuse H
    Endocr J; 1998 Apr; 45(2):183-9. PubMed ID: 9700471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A transient increase in serum procollagen 1 carboxyterminal peptide following effective treatment in prostate cancer patients with bone metastases.
    Nakashima J; Sumitomo M; Miyajima A; Jitsukawa S; Murai M
    Urol Int; 1997; 58(4):236-8. PubMed ID: 9253125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical markers for the detection of bone metastasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy.
    Tamada T; Sone T; Tomomitsu T; Jo Y; Tanaka H; Fukunaga M
    J Bone Miner Metab; 2001; 19(1):45-51. PubMed ID: 11156473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma.
    Kikuchi K; Sato S; Kadono T; Ihn H; Takehara K
    Arch Dermatol; 1994 Oct; 130(10):1269-72. PubMed ID: 7944508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary excretion of deoxypyridinoline in patients with breast cancer.
    Nguyen-Pamart M; Bonneterre J; Hecquet B
    Anticancer Res; 1995; 15(4):1601-3. PubMed ID: 7654055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Measurement of serum concentration with radioimmunoassay for carboxyterminal propeptide of type 1 procollagen].
    Yamamoto I; Takada M; Ohnaka Y; Yuu I; Yamamoto Y; Hamazu H; Morita R
    Kaku Igaku; 1993 May; 30(5):563-9. PubMed ID: 8336416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis.
    Sano M; Kushida K; Takahashi M; Ohishi T; Kawana K; Okada M; Inoue T
    Br J Cancer; 1994 Oct; 70(4):701-3. PubMed ID: 7917922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Assay of urinary pyridinoline and deoxypyridinoline as potential markers of the rate of bone resorption: usefulness of urinary pyridinoline and deoxypyridinoline in patients with prostate cancer with bone metastases].
    Takeuchi S; Yoshida K
    Nihon Hinyokika Gakkai Zasshi; 1994 Oct; 85(10):1521-7. PubMed ID: 7990300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.